Serum estradiol and progesterone assays vary substantially across laboratories because of differences in antibody specificity, calibration standards, detection platforms, and quality-control practices, meaning that a value within one laboratory's generic reference range may represent a clinically significant deficiency when interpreted against NaPro Peak-day-specific norms. NaProTECHNOLOGY requires consistent use of a single reference laboratory and interpretation relative to cycle-phase-specific NaPro standards rather than broad lab-generated reference intervals, to avoid missing subtle follicular or luteal phase defects that standard reporting would classify as normal.
why do my hormone levels differ between labs, progesterone test results not matching between hospitals, can I compare hormone results from different laboratories, my progesterone level was normal at one lab but low at another, how accurate are hormone blood tests, laboratory variation in fertility hormone testing, biologic variation versus assay variation, coefficient of variation progesterone assay, normal range establishment for reproductive hormones, laboratory-to-laboratory variation hormone testing, how to interpret progesterone levels from different labs, national hormone laboratory reference values, assay precision improvements reproductive hormones, time-linked variation menstrual cycle hormone testing, gestational week progesterone reference ranges, same specimen different lab results progesterone, establishing normal values for fertility hormones, quality control in reproductive hormone testing, creighton model hormone testing protocol, standardization of progesterone assays, interpreting hormone levels with different normal ranges, third-party payer understanding of lab variation, physician interpretation of laboratory hormone results, comparing local lab results to reference laboratory, how many specimens needed to correlate labs, pregnancy progesterone assay variability, menstrual cycle hormone assay differences, pope paul vi institute hormone laboratory, fertility hormone testing accuracy
Cite this article
Hilgers, T. W. (2004). Chapter 23: Differences Between Laboratories. *The Medical and Surgical Practice of NaProTECHNOLOGY*, 281-284.
Hilgers TW. Chapter 23: Differences Between Laboratories. The Medical and Surgical Practice of NaProTECHNOLOGY. 2004:281-284.
Hilgers, T. W. "Chapter 23: Differences Between Laboratories." *The Medical and Surgical Practice of NaProTECHNOLOGY*, 2004, pp. 281-284.
Hilgers TW2004The Medical and Surgical Practice of NaProTECHNOLOGY
Hilgers presents a refined classification of follicular and luteal phase deficiencies grounded in the integration of CrMS mucus pattern characteristics, cycle-phase-targeted estradiol and progesterone...
Hilgers TW et al.2004The Medical and Surgical Practice of NaProTECHNOLOGY
Family physicians are optimally positioned to introduce NaProTECHNOLOGY to patients presenting with infertility, irregular cycles, or recurrent pregnancy loss during routine primary care, enabling ear...
Hilgers TW2004The Medical and Surgical Practice of NaProTECHNOLOGY
Recurrent spontaneous abortion is examined through a systematic NaProTECHNOLOGY diagnostic framework that includes hormonal, anatomical, immunological, and infectious etiologies identified via CrMS cy...
Hilgers TW et al.2004The Medical and Surgical Practice of NaProTECHNOLOGY
Patients who have undergone multiple failed IVF cycles and are counseled to abandon fertility treatment represent a significant NaProTECHNOLOGY cohort in whom undiagnosed correctable pathology — inclu...